Table 1:
EGFR TKI Resistant Datasets
Data Set 138 | Data Set 235 | Data Set 340 | Data Set 440 | Data Set 539 | Data Set 636 | Data Set 736 | Data Set 836 | Data Set 936 | Data Set 1036 | |
---|---|---|---|---|---|---|---|---|---|---|
Accession | GSE80802 | GSE62118 | GSE79688 | GSE79688 | GSE117610 | GSE75602 | GSE75602 | GSE75602 | GSE75602 | GSE75602 |
CELLS LINE | HCC4006 | HCC827 | HCC827 | HCC4006 | PC9 | PC9 | PC9 | PC9 | PC9 | PC9 |
EGFR TKI | Gefitinib | Erlotinib | Gefitinib | Gefitinib | Gefitinib | Gefitinib | Gefitinib | Gefitinib | Gefitinib | Gefitinib |
MAX [C] | 100nM | 2uM | Up to 3uM | Up to 3uM | 50nM | 1mM | Not Specified | Not Specified | Not Specified | Not Specified |
LENGTH OF TX | 24 Hours | 47 Days | Not Specified | Not Specified | 6 Days | 24 Hours | Not Specified | Not Specified | 2 Weeks | 2 Weeks |
# of Samples (N) | Resistant (N=4) Control (N=4) |
Resistant (N=2) Control (N=2) |
Resistant (N=2) Control (N=2) |
Resistant (N=2) Control (N=2) |
Resistant (N=3) Control (N=2) |
Resistant (N=2) Control (N=2) |
Resistant (N=2) Control (N=2) |
Resistant (N=2) Control (N=2) |
Resistant (N=2) Control (N=2) |
Resistant (N=2) Control (N=2) |
# of DEGS | Up = 677 Down = 868 |
Up = 5,791 Down = 6,161 |
Up = 689 Down = 556 |
Up = 4,859 Down = 4,969 |
Up = 649 Down = 1,233 |
Up = 1,946 Down = 2,477 |
Up = 4,766 Down = 4,646 |
Up = 850 Down = 990 |
Up = 1,501 Down = 1,510 |
Up = 2,217 Down = 1,974 |
Raw RNA-SEQ datasets (.fasta files) were downloaded using the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database. Data was originally obtained by authors of the referenced manuscripts. Each dataset contains .fasta files for control cells and EGFR TKI resistant cells. This table details available information about the EGFR TKI used to make the resistant cell line, length of EGFR TKI treatment used to confer resistance, and the max EGFR TKI concentration that resistant cells were exposed to in their growth media. DEGs – differentially expressed genes (p < 0.05); TX – treatment.